JP2009532384A5 - - Google Patents

Download PDF

Info

Publication number
JP2009532384A5
JP2009532384A5 JP2009503312A JP2009503312A JP2009532384A5 JP 2009532384 A5 JP2009532384 A5 JP 2009532384A5 JP 2009503312 A JP2009503312 A JP 2009503312A JP 2009503312 A JP2009503312 A JP 2009503312A JP 2009532384 A5 JP2009532384 A5 JP 2009532384A5
Authority
JP
Japan
Prior art keywords
aaa
amino acid
ala
lys
amino acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009503312A
Other languages
English (en)
Japanese (ja)
Other versions
JP5355383B2 (ja
JP2009532384A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/065645 external-priority patent/WO2007115175A2/en
Publication of JP2009532384A publication Critical patent/JP2009532384A/ja
Publication of JP2009532384A5 publication Critical patent/JP2009532384A5/ja
Application granted granted Critical
Publication of JP5355383B2 publication Critical patent/JP5355383B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009503312A 2006-03-30 2007-03-30 環状ナトリウム利尿ペプチド構築物 Expired - Fee Related JP5355383B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US74396106P 2006-03-30 2006-03-30
US74396006P 2006-03-30 2006-03-30
US60/743,960 2006-03-30
US60/743,961 2006-03-30
PCT/US2007/065645 WO2007115175A2 (en) 2006-03-30 2007-03-30 Cyclic natriuretic peptide constructs

Publications (3)

Publication Number Publication Date
JP2009532384A JP2009532384A (ja) 2009-09-10
JP2009532384A5 true JP2009532384A5 (enExample) 2010-05-20
JP5355383B2 JP5355383B2 (ja) 2013-11-27

Family

ID=38564246

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009503312A Expired - Fee Related JP5355383B2 (ja) 2006-03-30 2007-03-30 環状ナトリウム利尿ペプチド構築物

Country Status (14)

Country Link
US (2) US7622440B2 (enExample)
EP (1) EP2001518B1 (enExample)
JP (1) JP5355383B2 (enExample)
KR (1) KR101434612B1 (enExample)
AU (1) AU2007233116B2 (enExample)
BR (1) BRPI0709427A2 (enExample)
CA (1) CA2647143A1 (enExample)
CO (1) CO6140040A2 (enExample)
DK (1) DK2001518T3 (enExample)
EA (1) EA016804B1 (enExample)
ES (1) ES2430323T3 (enExample)
IL (1) IL194262A (enExample)
MX (1) MX2008012663A (enExample)
WO (1) WO2007115175A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007233116B2 (en) 2006-03-30 2013-05-09 Palatin Technologies, Inc. Cyclic natriuretic peptide constructs
EA200802060A1 (ru) * 2006-03-30 2009-10-30 Палатин Текнолоджиз, Инк. Суррогаты аминокислот для пептидных конструктов
AU2007233123A1 (en) 2006-03-30 2007-10-11 Palatin Technologies, Inc. Linear natriuretic peptide constructs
US7964181B2 (en) 2006-03-30 2011-06-21 Palatin Technologies, Inc. Amino acid surrogates for peptidic constructs
US8114844B2 (en) 2006-03-30 2012-02-14 Palatin Technologies, Inc. Linear and cyclic melanocortin receptor-specific peptidomimetics
US8580746B2 (en) * 2006-03-30 2013-11-12 Palatin Technologies, Inc. Amide linkage cyclic natriuretic peptide constructs
EP2437772B1 (en) 2009-06-05 2017-12-06 13Therapeutics, Inc. Immunoregulatory peptides and methods of use
US9458198B1 (en) 2009-06-26 2016-10-04 Shire Orphan Therapies Gmbh Cyclic peptide-based NPR-B agonists
PH12012500562A1 (en) 2009-09-25 2012-10-22 Takeda Pharmaceuticals Co Novel npr-b antagonists
TW201121995A (en) 2009-12-18 2011-07-01 Alcon Res Ltd Novel NPR-B agonists
IE20100174A1 (en) * 2010-03-25 2012-02-29 Trinity College Dublin Transdermal administration of peptides
WO2011133735A2 (en) * 2010-04-21 2011-10-27 Palatin Technologies, Inc. Uses of natriuretic peptide constructs
US8580748B2 (en) 2011-04-06 2013-11-12 13Therapeutics, Inc. Peptides for the treatment of hearing
KR101867026B1 (ko) 2011-12-28 2018-07-20 대우조선해양 주식회사 밸러스트 수 처리 시스템의 미처리 수 처리 모듈
PH12021553101A1 (en) 2019-06-12 2023-10-02 Novartis Ag Natriuretic peptide receptor 1 antibodies and methods of use
CN114423447A (zh) * 2019-08-12 2022-04-29 生物马林药物股份有限公司 用于延释组合物的疏水性肽盐
WO2026136306A2 (en) * 2024-12-18 2026-06-25 Eli Lilly And Company Pde3b rna interference agents

Family Cites Families (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4251438A (en) 1979-06-14 1981-02-17 The Upjohn Company Piperazinone and piperazine polypeptides
US4341698A (en) 1979-06-21 1982-07-27 Richardson-Merrell Inc. Enkaphalin derivatives
US4496544A (en) 1983-11-10 1985-01-29 Washington University Atrial Peptides
US4952561A (en) 1984-02-07 1990-08-28 Merck & Co., Inc. Cardiac atrial peptides
JPS60184098A (ja) 1984-03-02 1985-09-19 Suntory Ltd 新規なペプチド及びこれを有効成分とする利尿剤
US4618600A (en) 1984-04-19 1986-10-21 Biotechnology Research Associates, J.V. Novel polypeptide diuretic/vasodilators
WO1985004870A1 (en) 1984-04-19 1985-11-07 Biotechnology Research Partners, Ltd. Novel atrial natriuretic/vasodilator polypeptides
US5212286A (en) 1984-04-19 1993-05-18 Scios Nova Inc. Atrial natriuretic/vasodilator peptide compounds
WO1985004872A1 (en) 1984-04-24 1985-11-07 The Salk Institute For Biological Studies Atrial peptide analogs
JPH0672155B2 (ja) 1984-08-24 1994-09-14 塩野義製薬株式会社 α−ｈＡＮＰ抗血清作製用ポリペプチド
US4609725A (en) 1984-10-09 1986-09-02 Merck & Co., Inc. Cardiac atrial peptides
US4757048A (en) 1985-11-05 1988-07-12 Biotechnology Research Associates J.V. Synthetic analogs of atrial natriuretic peptides
HUT45082A (en) * 1985-11-05 1988-05-30 Biotechnology Res Ass Process for preparing atrial natriuretic peptides
DE3614833A1 (de) 1986-01-16 1987-07-23 Hoechst Ag Peptide mit vasorelaxierender, natriuretischer und diuretischer wirkung, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung
US5057603A (en) 1986-01-31 1991-10-15 Merck & Co., Inc. Peptides having ANF activity
US4716147A (en) 1986-03-27 1987-12-29 Monsanto Company Synthetic airial peptides
EP0246795A3 (en) 1986-05-20 1990-04-04 Advanced Peptide Development Limited Synthetic natriuretic peptides
US5159061A (en) 1986-09-29 1992-10-27 Takeda Chemical Industries, Ltd. Atrial natriuretic peptide derivative
US4804650A (en) 1986-10-28 1989-02-14 Biotechnology Research Associates, J.V. Analogs of atrial natriuretic peptides
DK531986D0 (da) 1986-11-07 1986-11-07 Novo Industri As Peptider
DE3878231T2 (de) 1987-03-02 1993-05-27 Bissendorf Peptide Gmbh Neues cadiodilatin-fragment, prozess zu dessen herstellung und dessen anwendung.
US5095004A (en) 1987-03-25 1992-03-10 Bio-Mega Inc. Fluorine containing atrial natriuretic peptides
US5376635A (en) 1987-03-15 1994-12-27 Bio-Mega/Boehringer Ingelheim Research Inc. Fluorine containing atrial natriuretic peptides
US4816443A (en) 1987-05-19 1989-03-28 Merck & Co., Inc. Piptides having ANF activity
US5091366A (en) 1987-05-19 1992-02-25 Merck & Co., Inc. Peptides having ANF activity
IL86386A0 (en) 1987-05-21 1988-11-15 Merrell Dow Pharma Novel anf derivatives
JP2544929B2 (ja) 1987-06-17 1996-10-16 第一化学薬品 株式会社 新規生理活性ペプチド
US5047397A (en) 1988-08-26 1991-09-10 California Biotechnology Inc. Linear analogs of atrial natriuretic peptides
US4935492A (en) 1987-12-24 1990-06-19 California Biotechnology Inc. Cyclic analogs of atrial natriuretic peptides
EP0323740A3 (en) 1987-12-24 1990-12-12 California Biotechnology, Inc. Linear analogs of atrial natriuretic peptides
WO1989010935A1 (en) 1988-05-09 1989-11-16 Abbott Laboratories Atrial peptide derivatives
CA1339210C (en) 1988-05-31 1997-08-05 John Lewicki Recombinant techniques for production of novel natriuretic and vasodilator peptides
US5114923A (en) 1988-05-31 1992-05-19 California Biotechnology Inc. Recombinant techniques for production of novel natriuretic and vasodilator peptides
US5057495A (en) 1988-06-24 1991-10-15 Queen's University At Kingston Atrial hypotensive peptide
DK380288D0 (da) 1988-07-07 1988-07-07 Novo Industri As Hidtil ukendet peptider
JP2848411B2 (ja) 1988-08-18 1999-01-20 サイオス インコーポレイテッド 心房性ナトリウム利尿ペプチドクリアランス阻害剤
US4938763B1 (en) 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5106834A (en) 1988-12-27 1992-04-21 G. D. Searle & Co. Linear free-sulfhydryl-containing oligopeptide derivatives as antihypertensive agents
ATE124994T1 (de) 1989-03-01 1995-07-15 Daiichi Pure Chemicals Co Ltd Physiologisch aktives polypeptid und dna.
GR1001018B (el) 1989-05-24 1993-03-31 Abbott Lab Μεθοδος παρασκευης προδρομικων πεπτικων παραγωγων.
EP0479948B1 (en) 1989-06-23 1998-08-26 Genentech, Inc. Compositions and methods for the synthesis of natriuretic protein receptor b and methods of use
DK0532546T3 (da) 1990-05-10 1998-12-28 Nycomed Pharma As Farmaceutisk præparat indeholdende N-glycofuroler og N-ethylenglycoler
US5204328A (en) 1990-06-26 1993-04-20 Merck & Co., Inc. Peptides having atrial natriuretic factor activity
US5202239A (en) 1990-08-07 1993-04-13 Scios Nova Inc. Expression of recombinant polypeptides with improved purification
CA2089747A1 (en) 1990-10-11 1992-04-12 Gerd Schnorrenberg Cyclopeptides, a method of preparing them, and their use as drugs
JP2809533B2 (ja) 1991-01-31 1998-10-08 壽之 松尾 Ｃｎｐ類似体ペプチド
US5190922A (en) 1991-06-04 1993-03-02 Abbott Laboratories Terminally modified tri-, tetra- and pentapeptide anaphylatoxin receptor ligands
JP2925391B2 (ja) 1992-01-09 1999-07-28 サントリー株式会社 Ａｒｄｓ治療用医薬組成物
US5977070A (en) 1992-07-14 1999-11-02 Piazza; Christin Teresa Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis
AU6360394A (en) 1993-03-03 1994-09-26 Mayo Foundation For Medical Education And Research Vasonatrin peptide and analogs thereof
US5681811A (en) 1993-05-10 1997-10-28 Protein Delivery, Inc. Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same
US5359030A (en) 1993-05-10 1994-10-25 Protein Delivery, Inc. Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same
TW394760B (en) * 1993-09-07 2000-06-21 Hoffmann La Roche Novel Carboxamides, process for their preparation and pharmaceutical composition containing the same
US6525022B1 (en) 1993-11-12 2003-02-25 Genentech, Inc. Receptor specific atrial natriuretic peptides
CA2174517C (en) 1993-11-12 2007-01-02 David Lowe Receptor specific atrial natriuretic peptides
US5665704A (en) 1993-11-12 1997-09-09 Genentech, Inc. Receptor specific atrial natriuretic peptides
US5846932A (en) 1993-11-12 1998-12-08 Genentech, Inc. Receptor specific atrial natriuretic peptides
US5567662A (en) 1994-02-15 1996-10-22 The Dow Chemical Company Method of making metallic carbide powders
FR2717484A1 (fr) 1994-03-16 1995-09-22 Pf Medicament Nouveaux composés pseudo-bis-peptidiques analogues de la CCK, leur procédé de préparation, leur utilisation à titre de médicament et les compositions pharmaceutiques les comprenant .
US6150402A (en) 1994-08-15 2000-11-21 Loma Linda University Medical Center Natriuretic compounds
US5932462A (en) 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
US5672662A (en) 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
PT914344E (pt) 1996-03-04 2005-10-31 Scios Inc Ensaio e reagentes para a quantificacao de hbnp
US6028055A (en) 1996-10-22 2000-02-22 Genetech, Inc. Receptor selective BNP
ATE318580T1 (de) 1996-12-20 2006-03-15 Alza Corp Gelzusammensetzungen und verfahren
US5908825A (en) 1997-01-09 1999-06-01 University Of Maryland At Baltimore Dosage composition for nasal delivery and method of use of the same
US5965533A (en) 1997-05-23 1999-10-12 Baxter International Inc. Atrial natriuretic peptide (ANP) as an additive to peritoneal dialysis solutions
US6013630A (en) 1997-08-21 2000-01-11 Curagen Corporation Atrial natriuretic factor mutants and ischemic stroke
AU9487698A (en) 1997-09-11 1999-03-29 Music Foundation For Research Development Methods and compositions for treating cardiac and renal disorders with atrial natriuretic peptide and tissue kallikrein gene therapy
US6193991B1 (en) 1997-10-29 2001-02-27 Atul J. Shukla Biodegradable delivery systems of biologically active substances
AUPP254898A0 (en) * 1998-03-24 1998-04-23 University Of Queensland, The Peptide turn mimetics
EP1118329A4 (en) 1998-09-28 2004-12-15 Santen Pharmaceutical Co Ltd LACRYMAL SECRETION PROMOTERS OR OPHTHALMOLOGICAL DROPS CONTAINING NATRIURETIC PEPTIDES AS ACTIVE INGREDIENTS FOR TREATING KERATOCONJUNCTIVITY
US20040266673A1 (en) 2002-07-31 2004-12-30 Peter Bakis Long lasting natriuretic peptide derivatives
US6309633B1 (en) 1999-06-19 2001-10-30 Nobex Corporation Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
WO2001016295A1 (en) 1999-09-01 2001-03-08 The Regents Of The University Of California Novel natriuretic peptide receptors, interacting compounds and methods of regulating proliferation and/or survival of neurons
US6407211B1 (en) 1999-12-17 2002-06-18 Mayo Foundation For Medical Education And Research Chimeric natriuretic peptides
CA2394980C (en) 1999-12-22 2008-05-13 Shearwater Corporation Sterically hindered derivatives of water soluble polymers
US6911447B2 (en) 2001-04-25 2005-06-28 The Procter & Gamble Company Melanocortin receptor ligands
US6858580B2 (en) 2001-06-04 2005-02-22 Nobex Corporation Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
WO2003079979A2 (en) 2002-03-18 2003-10-02 Scios Inc. Method for treating congestive heart failure
US20040063630A1 (en) 2002-03-18 2004-04-01 Scios, Inc. Treatment of congestive heart failure with natriuretic peptide and a diuretic
US20050113286A1 (en) 2002-03-18 2005-05-26 Schreiner George F. Methods for treating congestive heart failure
SG159387A1 (en) 2002-11-26 2010-03-30 Biocon Ltd In Modified natriuretic compounds, conjugates, and uses thereof
EP1596887B1 (en) 2003-02-26 2022-03-23 Nektar Therapeutics Polymer-factor viii moiety conjugates
WO2005070446A1 (en) 2004-01-15 2005-08-04 Scios Inc. Method for treating cardiac remodeling following myocardial injury
AU2005207886A1 (en) 2004-01-27 2005-08-11 Compugen Usa, Inc. Novel brain natriuretic peptide variants and methods of use thereof
MX2007001667A (es) 2004-08-11 2007-10-02 Johnson & Johnson Aparato y metodo para el suministro transdermico de peptidos natriureticos.
AU2007233116B2 (en) 2006-03-30 2013-05-09 Palatin Technologies, Inc. Cyclic natriuretic peptide constructs
AU2007233123A1 (en) 2006-03-30 2007-10-11 Palatin Technologies, Inc. Linear natriuretic peptide constructs

Similar Documents

Publication Publication Date Title
JP2009532385A5 (enExample)
KR102812908B1 (ko) 인크레틴 유사체의 제조 방법
FI120691B (fi) Ei-terapeuttinen menetelmä kasvuhormonin vapautumisen edistämiseksi eläimessä
JP2011511778A5 (enExample)
JP2011502159A5 (enExample)
JP2024520861A (ja) 遺伝性ヘモクロマトーシスの治療のためのヘプシジン模倣体
KR950702578A (ko) 파라티로이드 호르몬(pth) 및 파라티로이드 호르몬 관련 펩티드(pthrp)의 유사체, 이들의 합성 및 골다공증 치료를 위한 이들의 용도(analogs of pth and pthrp, their synthesis and use for the treatment of osteoporosis)
JP2011524418A5 (enExample)
KR20140100937A (ko) 펩티도미메틱 거대고리
ES2200178T3 (es) Analogos de hgh-rh(1-29)nh2 que tienen actividad antagonista.
JP2024513391A5 (enExample)
JP2013518115A5 (enExample)
JP2010189398A (ja) Ｐａｃａｐのペプチド類似体
JPS63154699A (ja) バソプレシン拮抗剤
US7452865B2 (en) Antagonistic analogs of GH RH (2003)
CN101983068B (zh) N末端和c末端取代的人gh-rh拮抗类似物
JP2837352B2 (ja) 胃腸運動活性を抑制するモチリン類似ポリペプチド
IL171204A (en) Compounds and pharmaceutical compositions containing them and use thereof for the preparation of medicaments
DE69528531T2 (de) D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet
US20110195900A1 (en) Peptidic pth receptor agonists
KR100360975B1 (ko) 위장운동자극활성을가지는폴리펩티드
JPH04502629A (ja) 還元不可逆性ボンベシンアンタゴニスト
CN115515937A (zh) 用于合成肽模拟物的二聚体
JPH09221500A (ja) カルシトニン類似体
RU97112094A (ru) Ингибиторы фибронектиновой адгезии